As a result an antibody has been generated that only recognizes the active phosphorylated form of ZIP7 [46] and this antibody can be used to recognize higher grade breast cancers [48] which have greater levels of ZIP7. The gene discussed is SLC39A7; the disease is breast carcinoma.